Suggestions
Franco Marincola
Experienced Chief Scientific Officer and Accomplished Researcher
Franco Marincola, also known as Francesco Marincola, is a distinguished scientist and executive in the biotechnology industry. Here are the key details about his career and background:
Current Position
Franco Marincola currently serves as the Chief Scientific Officer at Sonata Therapeutics, a position he has held since March 2023.1 In this role, he is responsible for accelerating the company's vision to deliver novel therapeutics that reprogram diseased cells.3
Previous Positions
Prior to joining Sonata Therapeutics, Marincola held several notable positions:
- Global Head of Research at Kite Pharma (January 2021 - March 2023)5
- President and Chief Scientific Officer at Refuge Biotechnologies Inc. in Menlo Park, California (April 2018 - March 2020)4
- Distinguished Research Fellow at AbbVie (February 2017 - March 2020)
- Chief Research Officer at Sidra Medical and Research Center (March 2013 - February 2017)
Academic Background
Marincola received his Medical Doctor degree from the University of Milan, Italy, specializing in Immunology and Genetics (1972-1978). He also completed his surgery training at Stanford University in California.2
Research and Contributions
Throughout his career, Marincola has made significant contributions to the field of immunology and cancer research:
- He has authored more than 600 peer-reviewed scientific articles.23
- His work has deepened the understanding of mechanisms leading to tumor rejection and transplant organ rejection by the immune system.2
- Marincola has been a pioneering contributor to the understanding of tumor microenvironments.3
Professional Affiliations
- Past President of the Society for Immunotherapy of Cancer (SITC)23
- Editor-in-Chief of the Journal of Translational Medicine and Translational Medicine Communications2
- Editor of several scientific books, including the SITC-affiliated textbook "Cancer Immunotherapy – Principles and Practice"2
Franco Marincola's extensive experience in both academia and industry, combined with his expertise in immunology and cell therapy research, has established him as a prominent figure in the biotechnology field.
